摘要
最近,纳米粒子使针对细胞组织的治疗药物的靶向给药成为可能,这对基础生物科学,制药工业,临床前医学和转化医学造成了重大影响。这些材料的对药代动力学,生物分布和治疗分子的长期活动进行改造以适应特殊疾病和避免不良反应的能力是很有前途的。但是来自体循环的靶向纳米粒子的治疗效率很低,而且我们对体内活动的基本过程的传导了解有限。因此,我们很难作出这些材料的最佳合理设计以期达到最大效能。最近,多模式和多尺度成像技术的兴起有助于我们对这些过程的进一步认识。治疗诊断成像剂能给出实时的量化的药物分布和治疗反应的显示值,多模式成像平台可以进行从细胞到组织水平的分布的多尺度分析,而且令人振奋的是,在活体组织镜检中应用提供了细胞水平上的关键认识。在这篇综述中,我们讲述了多尺度成像如何使我们能够完善纳米药物,并且讨论了进一步促进其临床转化的未来方向。
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
Current Drug Targets
Title:Multiscale Imaging of Nanoparticle Drug Delivery
Volume: 16 Issue: 6
Author(s): Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith
Affiliation:
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
摘要: Nanoparticles have recently had a major impact on basic biosciences, the pharmaceutical industry, and preclinical and translational medicine by enabling targeted delivery of therapeutic cargo to cells and tissues. The capacity to specifically tailor the pharmacokinetics, biodistribution, and longterm fate of therapeutic molecules for specific diseases and to avoid off-target side effects is a tremendously promising capability of these materials. However targeting of nanoparticle therapies from systemic circulation is very inefficient, and our understanding of the fundamental processes dictating in vivo fate remains limited, making it challenging to determine how to optimally and rationally design these materials for maximum efficacy. Recently multi-modal, multi-scale imaging technologies have emerged that have helped to improve our insight into these processes. Theranostic imaging agents have provided real-time and quantitative readouts of drug distribution and therapeutic response, multimodal imaging platforms have allowed a multi-scale analysis of distribution from the levels of cells to tissues, and exciting applications in live-animal tissue microscopy have provided key insights at the cellular level. In this review, we describe how multiscale imaging has shaped our ability to optimize nanoparticle drugs and discuss future directions that are expected to further catalyze clinical translation.
Export Options
About this article
Cite this article as:
Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith , Multiscale Imaging of Nanoparticle Drug Delivery, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450116666150202163022
DOI https://dx.doi.org/10.2174/1389450116666150202163022 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Recent Patents on Electrospun Biomedical Nanostructures: An Overview
Recent Patents on Biomedical Engineering (Discontinued) Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies
Current Cancer Therapy Reviews Circulating miR-126 as a Potential Non-invasive Biomarker for Intracranial Aneurysmal Rupture: A Pilot Study
Current Neurovascular Research Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Statins Exert Multiple Beneficial Effects on Patients Undergoing Percutaneous Revascularization Procedures
Current Drug Targets Overview of Therapeutic Potential of Rapamycin for Coronary Artery Diseases in the Era of the Drug-Eluting Stent
Vascular Disease Prevention (Discontinued) Pediatric Chronic Daily Headache
Current Pediatric Reviews Endothelin-1 and Human Platelets
Current Vascular Pharmacology Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Current Pharmaceutical Design Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Current Vascular Pharmacology Editorial: Neuronanomedicine - (Part II)
Current Medicinal Chemistry Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update
Current Vascular Pharmacology The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Assessment of Cardiac Performance with Magnetic Resonance Imaging
Current Cardiology Reviews 3D Printing in Modern Cardiology
Current Pharmaceutical Design 3D Cell and Scaffold Patterning Strategies in Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design
Current Vascular Pharmacology Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry